Loading company details...
Latest Form 4 (Nov 12, 2026): Jeffrey S. Martini (Chief Scientific Officer): Exercise/Conversion of 4,266 shares, $32.1K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 12, 2026 | Jeffrey S. Martini, Chief Scientific Officer | Exercise/Conversion | 4,266 | $32.1K |
| Oct 23, 2026 | Kathleen Goin, Chief Operating Officer | Exercise/Conversion | 2,165 | $15.5K |
| Oct 14, 2026 | George M. Jenkins | Sale | 5,095 | $675.7K |
| Sep 18, 2026 | Kathleen Goin, Chief Operating Officer | Exercise/Conversion | 2,154 | $15.4K |
| Sep 16, 2026 | George M. Jenkins | Sale | 6,520 | $982.0K |
| Sep 4, 2026 | Christopher P. Kiritsy | Exercise/Conversion | 313 | $39.8K |
| Aug 20, 2026 | Kathleen Goin, Chief Operating Officer | Exercise/Conversion | 2,154 | $15.4K |
| Jul 17, 2026 | Kathleen Goin, Chief Operating Officer | Exercise/Conversion | 2,154 | $15.4K |
| Jul 1, 2026 | Matthew Pauls | Grant/Award | 6,000 | n/a |
| Jun 22, 2026 | Kathleen Goin, Chief Operating Officer | Exercise/Conversion | 2,154 | $15.4K |